Table 2.
Follicle growth, clinical pregnancy, and live birth rates in Group OS classified by age at initiation of follow-up.
| Age Group | |||
|---|---|---|---|
| a (<35) | b (35–39) | c (≥40) | |
| Follicle growth rate | 51.6% (81/157) | 49.7% (91/183) | 39.3% (35/89) |
| Clinical pregnancy rate | 26.8% (42/157)** | 12.0% (22/183) | 2.2% (2/89) |
| Live birth rate | 21.0% (33/157)** | 8.7% (16/183) | 1.1% (1/89) |
| Abortion rate | 21.4% (9/42) | 27.3% (6/22) | 50.0% (1/2) |
Group OS, patients who underwent ovarian stimulation by hMG/recFSH with GnRH-a under hormone replacement; Group HR, patients who were observed with estrogen and progestin replacement only.
a, patients <35 years; b, patients 35–39 years; c, patients ≥40 years of age at initiation of follow-up at Rose Ladies Clinic.
**p < 0.01.